Rituximab
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference83 articles.
1. Ten years of rituximab in NHL
2. Economic Burden of Follicular Non-Hodgkinʼs Lymphoma
3. Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
4. Rituximab for the Treatment of Non-Hodgkinʼs Lymphoma and Chronic Lymphocytic Leukaemia
5. Rituximab and chemotherapy in diffuse large B-cell lymphoma
Cited by 163 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring treatment options in cancer: tumor treatment strategies;Signal Transduction and Targeted Therapy;2024-07-17
2. Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody;Blood Cancer Journal;2024-04-18
3. Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future;Frontiers in Cardiovascular Medicine;2023-08-30
4. Novel neutralizing mouse-human chimeric monoclonal antibodies against the SARS-CoV-2 receptor binding domain;Journal of Medical Microbiology;2023-06-30
5. Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India;Cancer Chemotherapy and Pharmacology;2023-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3